Gruia Gabriela
SEC insider (Form 3/4/5 filer). CIK 0001860326. Director at Aprea Therapeutics, Inc. (APRE) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in DOYLESTOWN, PA.
Companies Gruia Gabriela has filed insider reports for
- Aprea Therapeutics, Inc. (APRE): Director
- TScan Therapeutics, Inc. (TCRX): Director
- Molecular Templates, Inc. (MTEM): Director
Gruia Gabriela
CIK: 0001860326
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 16, 2026APRE
Aprea Therapeutics, Inc.
AwardDirect3.1K shares- - May 20, 2026TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Jun 30, 2025TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Jun 5, 2025APRE
Aprea Therapeutics, Inc.
AwardDirect1K shares- - Sep 27, 2024MTEM
Molecular Templates, Inc.
AwardDirectStock Option (right to buy)
1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  APRE Aprea Therapeutics, Inc. | Award | 3,135 | - | $0 | Direct |
| May 20, 2026 |  TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Jun 30, 2025 | TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | Award | 1,045 | - | - | Direct |
| Sep 27, 2024 |  MTEM Molecular Templates, Inc. | Award Stock Option (right to buy) | 1,000 | - | - | Direct |
1-5 of 5 transactions